Jennifer Doudna
Angel Investor
San Francisco, United States
Jennifer Doudna is a Series A investor in San Francisco focused on Biotechnology and Genetics. Jennifer Doudna is based out of Berkeley, California and is the Co-Founder of Azalea Therapeutics. Jennifer previously worked at Yale University as a Professor. Jennifer Doudna attended Pomona College and Harvard University.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jennifer Doudna invests in
Stages Jennifer Doudna invests in
Countries Jennifer Doudna invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 3 (100%)
- Genetics 1 (33%)
- Robotics 1 (33%)
- Software 1 (33%)
- Health Care 1 (33%)
Stage
- Series A 2 (67%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tinctorium is a provider of indigo dyeing solutions intended to reduce chemical usage in the denim supply chain.The company's offerings include harnessing the power of biotechnology by mirroring a natural plant process within microbes to produce colors using completely renewable sources, providing the denim industry an alternative to makedenim. | $14.6M / Series A / Jul 27, 2022 | ||
| Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platformvertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs.By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology.The company was founded in 2012 and is based in Redwood City, California. | $41M / Series B / Jan 04, 2017 | ||
| Caribou Biosciences is a operator of a medical technology company intended to analyze cell and genome engineering. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling development oftherapeutics for agricultural biotechnology, industrial biotechnology and basic and applied biological research. | $11M / Series A / Mar 25, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jennifer Doudna invest in?
Jennifer Doudna invests primarily in Biotechnology, Genetics and Robotics startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jennifer Doudna?
Public channels for Jennifer Doudna include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jennifer Doudna last invest?
The most recent investment recorded for Jennifer Doudna closed in Jul 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
